UK first to approve CRISPR treatment for diseases: what you need to know
UK first to approve CRISPR treatment for diseases: what you need to know
复制标题
英国第一个批准 CRISPR 治疗疾病：你需要知道什么
DOI：
10.1038/d41586-023-03590-6
复制
发表时间：
2023
期刊：
影响因子：
64.8
通讯作者：
Carissa Wong
中科院分区：
文献类型：
--
作者：
Carissa Wong
这一里程碑式的决定可能会改变镰状细胞疾病和β地中海贫血症的治疗--但这项技术代价高昂。这一里程碑式的决定可能会改变镰状细胞疾病和β地中海贫血症的治疗--但这项技术代价高昂。来源：科学之眼/科学图片库，受镰状细胞性贫血影响的红细胞的彩色扫描电子显微照片。镰状细胞性贫血影响红细胞的彩色扫描电子显微镜。
The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive. The landmark decision could transform the treatment of sickle-cell disease and β-thalassaemia — but the technology is expensive. Credit: Eye Of Science/Science Photo Library Coloured scanning electron micrograph of red blood cells affected by sickle cell anaemia. Coloured scanning electron micrograph of red blood cells affected by sickle cell anaemia.